| Literature DB >> 2215269 |
Abstract
Oestrogens cure climacteric complaints and prevent the late sequelae of oestrogen deficiency. Prevention of myocardial infarction and of osteoporosis is now the main argument for long-term substitution of oestrogens and progestogens in the post-menopause and leads to a reduction of overall morbidity and mortality in users. Indications, contraindications, some side effects, risk-benefit and cost-benefit considerations are discussed and practical advice for oestrogen medication with regard to doses, preparations and the addition of progestogens is given.Entities:
Keywords: Adult; Age Factors; Behavior; Biology; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Decreased Libido; Delivery Of Health Care; Demographic Factors; Developed Countries; Diseases; Endocrine System; Estradiol; Estriol; Estrogenic Substances, Conjugated; Estrogens; Estrone; Europe; Family Planning; Germany; Health Services; Heart Diseases; Hormones; Injectables; Levonorgestrel; Literature Review; Lynestrenol; Medicine; Medrogestone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Myocardial Infarction; Norethindrone; Norethindrone Acetate; Oral Contraceptives; Physiology; Population; Population Characteristics; Progestational Hormones; Progesterone; Reproduction; Sex Behavior; Treatment; Vaginal Abnormalities; Western Europe
Mesh：
Substances：
Year: 1990 PMID： 2215269 DOI： 10.1016/0378-5122(90)90004-p
Source DB: PubMed Journal: Maturitas ISSN： 0378-5122 Impact factor: 4.342